Coronavirus Update: Novartis Joins Antiviral Therapies Search With Novel DARPin Alliance
Plus: Japan Passes Bill For Free Vaccines
Swiss biotech Molecular Partners will receive upfront payment of CHF60m, including equity.

Swiss biotech Molecular Partners will receive upfront payment of CHF60m, including equity.